Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles

Abstract

AbstractThe alpha-synuclein (αSyn) seeding amplification assay (SAA) that allows the generation of disease-specific in vitro seeded fibrils (SAA fibrils) is used as a research tool to study the connection between the structure ofαSyn fibrils, cellular seeding/spreading, and the clinico-pathological manifestations of different synucleinopathies. However, structural differences between human brain-derived and SAAαSyn fibrils have been recently highlighted. Here, we characterize biophysical properties of the human brain-derivedαSyn fibrils from the brains of patients with Parkinson’s disease with and without dementia (PD, PDD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA) and compare them to the ‘model’ SAA fibrils. We report that the brain-derivedαSyn fibrils show distinct biochemical profiles, which were not replicated in the corresponding SAA fibrils. Furthermore, the brain-derivedαSyn fibrils from all synucleinopathies displayed a mixture of ‘straight’ and ‘twisted’ microscopic structures. However, the PD, PDD, and DLB SAA fibrils had a ‘straight’ structure, whereas MSA SAA fibrils showed a ‘twisted’ structure. Finally, the brain-derivedαSyn fibrils from all four synucleinopathies were phosphorylated (S129). However, the phosphorylation pattern was not maintained in the SAA fibrils, where only PDD and DLB SAA fibrils showed weak signs of phosphorylation. Our findings demonstrate the limitation of the SAA fibrils modelling the brain-derivedαSyn fibrils and pay attention to the necessity of deepening the understanding of the SAA fibrillation methodology.